Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation cover image

21: Unleashing Effective QbD Strategies to Master Cell Therapy with Shin Kawamata - Part 1

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation

00:00

Quality Requirements for Mass Culture of Stem Cells and CAR-T Therapy

Exploring the specific quality requirements for mass culture of stem cells, focusing on maintaining differentiation ability, minimizing mitochondria activation, and highlighting glycolytic pathways for IPSC and MSC. The chapter also discusses the importance of prolonging culture for pharmacological efficacy and maintaining cell quality, as well as the significance of maintaining youth in CAR-T therapy through markers and metabolic considerations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app